Positron Emission Tomography/Computed Tomography with F-18-fluorocholine for Restaging of Prostate Cancer Patients: Meaningful at PSA < 5 ng/ml?

CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS

Kimberly A. Roehl, Misop Han, Christian G. Ramos et al. · The Journal of Urology · 2004 · 860 citations

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

Alan W. Partin, Charles R. Pound, Jay D. Pearson et al. · Urology · 1994 · 406 citations

Urology, Surgical Oncology, Genitourinary Cancer +7

Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

Timothy R. DeGrado, Robert E. Coleman, S Wang et al. · PubMed · 2001 · 369 citations

18F-labeled Choline, Engineering, Chemoprevention Strategy +21

Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.

Timothy R. DeGrado, S. W. BALDWIN, S Wang et al. · PubMed · 2001 · 334 citations

PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCER

Judd W. Moul · The Journal of Urology · 2000 · 324 citations